A recent study reported, in a cohort of 426 patients with primary breast cancer, that elevated expression of Aurora-A and SURVIVIN, together with BTAK gene amplification, is correlated with increased CIN and shorter survival (74). The gene discussed is AURKA; the disease is cervical squamous intraepithelial neoplasia.